Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

TiO2 Still A California Prop 65 Target; EU Commission Returns To SCCS With New Safety Questions

Oct 12 2022

• By Ryan Nelson

Related Content

TiO2 Prop 65 Dismissal Offers Lessons, Renews Hope For Industry

Aug 31 2015

Future Use Of Titanium Dioxide In Spray And Powder Cosmetics Hinges On SCCS Review

Feb 20 2020

Beauty Firms Hit With Prop 65 Notice: Don’t Ignore Or Retailers May ‘Blackball’ You

Mar 27 2022

Airborne TiO2 Of Respirable Size? Litigation Goes On Under Prop 65

Jul 23 2014

Additional Topics

United States US States Europe Cosmetic Ingredients Legal Issues Safety Regulation Cosmetics Consumer

More from Ingredients & Safety

More from HBW Insight

Twitter feed RSS feed RSS feed

About Us

Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us

Customer Service
SubscribeOpens in new window
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window

Copyright © 2025 Pharma Intelligence UK Limited (Citeline), a Norstella company Pharma Intelligence UK Limited is a company registered in England and Wales with company number 13787459 whose registered.